Cargando…

Mortality-Related Risk Factors and Novel Antimicrobial Regimens for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review

OBJECTIVE: Carbapenem-resistant Enterobacteriaceae (CRE) has become a significant public health problem in the last decade. We aimed to explore the risk factors of mortality in patients with CRE infections and to focus on the current evidence on antimicrobial regimens for CRE infections, particularl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Qin, Chen, Jinglan, Sun, Shusen, Deng, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9717588/ https://www.ncbi.nlm.nih.gov/pubmed/36465807 http://dx.doi.org/10.2147/IDR.S390635

Ejemplares similares

Mortality rate and factors associated with mortality of carbapenem-resistant Enterobacteriaceae infection
por: So-ngern, Apichart, et al.
Publicado: (2023)

Prevalence of Carbapenem-Resistant Enterobacteriaceae in Western Saudi Arabia and Increasing Trends in the Antimicrobial Resistance of Enterobacteriaceae
por: Taha, Rbab, et al.
Publicado: (2023)

Risk factor for mortality associated with carbapenem-resistant Enterobacteriacea infections
por: Carrilho, Cláudia MDM, et al.
Publicado: (2013)

Risk Factors for Mortality and Antimicrobial Regimens in Pediatric Intensive Care Unit Patients with Carbapenem-Resistant Enterobacteriaceae Infections: A Six-Year Retrospective Study
por: Liu, Peng, et al.
Publicado: (2022)

Antimicrobial Activity of Lactobacillus Species Against Carbapenem-Resistant Enterobacteriaceae
por: Chen, Chi-Chung, et al.
Publicado: (2019)

Resistance Pattern of Carbapenem on Enterobacteriaceae
por: Pokharel, Khilasa, et al.
Publicado: (2018)

Clinical and Mortality Risk Factors in Bloodstream Infections with Carbapenem-Resistant Enterobacteriaceae
por: Li, Xiaopeng, et al.
Publicado: (2017)

Fosfomycin Dosing Regimens based on Monte Carlo Simulation for Treated Carbapenem-Resistant Enterobacteriaceae Infection
por: Kanchanasurakit, Sukrit, et al.
Publicado: (2020)

Impact of carbapenem resistance on mortality in patients infected with Enterobacteriaceae: a systematic review and meta-analysis
por: Zhou, Ruyin, et al.
Publicado: (2021)

Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
por: Falagas, Matthew E., et al.
Publicado: (2014)

Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
por: Morrill, Haley J., et al.
Publicado: (2015)

Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects
por: Jean, Shio-Shin, et al.
Publicado: (2018)

Assessment of Effective Antimicrobial Regimens and Mortality-Related Risk Factors for Bloodstream Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
por: Gu, Shumin, et al.
Publicado: (2023)

417. Factors associated with 30-day Mortality in Carbapenems-resistant Enterobacteriaceae Infections
por: Osaithai, Naphol, et al.
Publicado: (2022)

Role of Double-Carbapenem Regimen in the Treatment of Infections due to Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae: A Single-Center, Observational Study
por: Cancelli, F., et al.
Publicado: (2018)

Vital Signs: Carbapenem-Resistant Enterobacteriaceae
por: Jacob, Jesse T., et al.
Publicado: (2013)

Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis()
por: Abboud, Cely Saad, et al.
Publicado: (2017)

Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children
por: Chiotos, Kathleen, et al.
Publicado: (2018)

Evaluation of Resistance Mechanisms in Carbapenem-Resistant Enterobacteriaceae
por: Alizadeh, Naser, et al.
Publicado: (2020)

Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae
por: Petty, Lindsay A, et al.
Publicado: (2018)

2416. Risk Factors and Outcomes of Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae Compared With Carbapenem Susceptible Enterobacteriaceae
por: Mahmood, Syed Faisal
Publicado: (2018)

Predictors of Mortality and Drug Resistance Among Carbapenem-Resistant Enterobacteriaceae-Infected Pancreatic Necrosis Patients
por: Wu, Di, et al.
Publicado: (2021)

Treatment of Carbapenem-Resistant Enterobacteriaceae Infections with Ceftazidime-Avibactam
por: Rahmati, Elham, et al.
Publicado: (2017)

Carbapenem Resistant Enterobacteriaceae infections in Houston, Texas: An outline
por: Rehman, Hafeez, et al.
Publicado: (2017)

Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections
por: Suay-García, Beatriz, et al.
Publicado: (2019)

Clinical Characteristics and Associated Factors for Mortality in Patients with Carbapenem-Resistant Enterobacteriaceae Bloodstream Infection
por: Ahn, Jin Young, et al.
Publicado: (2023)

Factors Associated with Mortality in Carbapenem-Resistant Enterobacteriaceae Bacteremia: Focus on Antibiotic Therapy
por: Pillinger, Kelly E, et al.
Publicado: (2017)

Factors associated with acquisition of carbapenem-resistant Enterobacteriaceae
por: Lavagnoli, Lilian Silva, et al.
Publicado: (2017)

369 Outcomes of Patients with Carbapenem-Resistant Enterobacteriaceae
por: Raybould, Jillian, et al.
Publicado: (2014)

Emerging superbugs: The threat of Carbapenem Resistant Enterobacteriaceae
por: Dong, Le Thanh, et al.
Publicado: (2020)

Intestinal Dysbiosis in Carriers of Carbapenem-Resistant Enterobacteriaceae
por: Korach-Rechtman, Hila, et al.
Publicado: (2020)

Antibiotic Susceptibility Patterns for Carbapenem-Resistant Enterobacteriaceae
por: Armin, Shahnaz, et al.
Publicado: (2023)

A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States
por: Livorsi, Daniel J., et al.
Publicado: (2018)

Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China
por: Ding, Yijun, et al.
Publicado: (2019)

A Cohort Study of the Impact of Carbapenem-Resistant Enterobacteriaceae Infections on Mortality of Patients Presenting with Sepsis
por: Sabino, Sabrina, et al.
Publicado: (2019)

2130. Detection of Carbapenemase-Producing Organisms and Impact on Antimicrobial Utilization for Carbapenem-Resistant Enterobacteriaceae (CRE) Infections
por: Minor, Sarah Brooks, et al.
Publicado: (2019)

Carbapenem-Resistant Enterobacteriaceae Infections in Patients on Renal Replacement Therapy
por: Eilertson, Brandon, et al.
Publicado: (2017)

Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options
por: Sheu, Chau-Chyun, et al.
Publicado: (2019)

Socioeconomic Burden of Bloodstream Infections Caused by Carbapenem-Resistant Enterobacteriaceae
por: Zhu, Yunying, et al.
Publicado: (2021)

Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis
por: Ni, Wentao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hnon3li7uefqm5cdjvm8lb4g9o